MiR-339-5p inhibits breast cancer cell migration and invasion in vitro and may be a potential biomarker for breast cancer prognosis
about
MicroRNA-7 inhibits tumor metastasis and reverses epithelial-mesenchymal transition through AKT/ERK1/2 inactivation by targeting EGFR in epithelial ovarian cancerB-cell lymphoma 6 protein stimulates oncogenicity of human breast cancer cellsmiR-320a is an independent prognostic biomarker for invasive breast cancerLoss of miR-133a expression associated with poor survival of breast cancer and restoration of miR-133a expression inhibited breast cancer cell growth and invasion.miR-340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c-Met.Associations of miRNA polymorphisms and female physiological characteristics with breast cancer risk in Chinese population.TFPI alpha and beta regulate mRNAs and microRNAs involved in cancer biology and in the immune system in breast cancer cells.MicroRNA-339-5p inhibits colorectal tumorigenesis through regulation of the MDM2/p53 signaling.MiR-339-5p regulates the growth, colony formation and metastasis of colorectal cancer cells by targeting PRL-1microRNA-339-5p modulates Na+/I- symporter-mediated radioiodide uptake.Identification and characterization of novel and differentially expressed microRNAs in peripheral blood from healthy and mastitis Holstein cattle by deep sequencing.Integrated microRNA and mRNA responses to acute human left ventricular ischemia.Prognostic significance of phosphorylated signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3 expression in hepatocellular carcinoma.Prolactin Inhibits BCL6 Expression in Breast Cancer Cells through a MicroRNA-339-5p-Dependent PathwayInferred miRNA activity identifies miRNA-mediated regulatory networks underlying multiple cancers.MicroRNA-339 and microRNA-556 regulate Klotho expression in vitroMicroRNA-339-5p down-regulates protein expression of β-site amyloid precursor protein-cleaving enzyme 1 (BACE1) in human primary brain cultures and is reduced in brain tissue specimens of Alzheimer disease subjectsMicroRNAs (miRNAs) in cancer invasion and metastasis: therapeutic approaches based on metastasis-related miRNAs.microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer.Gene expression profile analysis in response to α1,2-fucosyl transferase (FUT1) gene transfection in epithelial ovarian carcinoma cells.Lactogenic hormones alter cellular and extracellular microRNA expression in bovine mammary epithelial cell cultureMutual interaction between BCL6 and miRNAs contributing to the pathogenesis of various cancers.MicroRNA-7 suppresses the homing and migration potential of human endothelial cells to highly metastatic human breast cancer cells.miR-339-5p inhibits migration and invasion in ovarian cancer cell lines by targeting NACC1 and BCL6.MicroRNA-339, an epigenetic modulating target is involved in human gastric carcinogenesis through targeting NOVA1.miR-339-5p regulates the p53 tumor-suppressor pathway by targeting MDM2.Genetic variants in microRNA and microRNA biogenesis pathway genes and breast cancer risk among women of African ancestry.MicroRNA expression profiling of porcine mammary epithelial cells after challenge with Escherichia coli in vitro.Identification of circular RNAs as a promising new class of diagnostic biomarkers for human breast cancer.The regulation of the p53/MDM2 feedback loop by microRNAs.miR-339-5p inhibits cell migration and invasion in vitro and may be associated with the tumor-node-metastasis staging and lymph node metastasis of non-small cell lung cancerMiR-23a modulates X-linked inhibitor of apoptosis-mediated autophagy in human luminal breast cancer cell lines.Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs.miR-339-5p downregulation contributes to Taxol resistance in small-cell lung cancer by targeting α1,2-fucosyltransferase 1.Genome-wide miRNA signatures of human longevity.MiR-339 depresses cell proliferation via directly targeting S-phase kinase-associated protein 2 mRNA in lung cancer.High expressions of BCL6 and Lewis y antigen are correlated with high tumor burden and poor prognosis in epithelial ovarian cancer.Application of serum microRNA-9-5p, 21-5p, and 223-3p combined with tumor markers in the diagnosis of non-small-cell lung cancer in Yunnan in southwestern China.miR-339-5p inhibits metastasis of non-small cell lung cancer by regulating the epithelial-to-mesenchymal transition.TSPAN15 interacts with BTRC to promote oesophageal squamous cell carcinoma metastasis via activating NF-κB signaling.
P2860
Q33590704-DDF4F367-338E-4A42-9FBA-3829B18E363CQ33786387-C9962158-66D4-4B57-A624-44760B039A54Q33967807-6E18CE84-FEFC-4467-9DD7-4D9B27735AF5Q34146970-B4C7A236-52D7-4F67-9816-35DD3F9F3A6BQ34194306-D7BDA355-F48A-43D6-9039-08F5D7A05DB4Q34231578-CA74CA64-683B-43D8-A754-94DAF7A0A9FCQ34448038-0CDC640F-7244-4A74-A893-3A3A69BCACAAQ34619254-1A881851-99EB-473B-961D-C97780444713Q34733682-4B3E0214-CEC9-4557-B5D2-229E3938276BQ34982847-10A1C4D6-BE48-4CE4-8415-8C3503421FABQ35059627-91C6BE9B-5712-462E-B378-5B6A85B0253BQ36122833-6F10650F-130A-4450-AFD5-B5D9C6774E81Q36230775-B72267F8-FDFA-442E-AE5F-BDD3C8F1F425Q36768980-7CA97F48-B68F-4D25-83B6-6DF98576F62BQ37220598-3ACDD03E-3663-4F1F-A2A0-3B6E3E6D10C7Q37470934-DFB75267-7DD0-46B0-8962-A12062166AD0Q37596385-DF215331-8BFF-4596-9965-6A85EEEF00F5Q37828424-AB3A1475-C06B-4926-8A27-316CBC2915AAQ38336073-894554D1-B28C-4FB9-BFFE-A68F16B22084Q38441314-2C972CEC-AB63-4D8A-852A-8CCD94FF2522Q38526962-F56C4A3D-70DD-4D1C-9247-81E16AE01547Q38537155-D3126501-C9CF-44B1-B240-F69E587CAC0BQ38701611-DA125E90-9908-4E31-B245-ECB7A7020FD7Q38820618-23524824-A987-48E7-9ECC-8F7955780384Q38833760-BB241637-FAF0-4CF5-A82C-0B1727F02371Q38989592-2922BA3A-7FCC-4C62-A753-1E1CE3F09582Q39373193-D2559EE4-091E-4871-98EC-306CDAB10D5DQ40081343-E88BF035-50BB-45E9-9986-1A078FA91172Q40209662-317A9D4C-0F3E-44E8-B1C5-9B06FF5594DBQ40784946-8D2DBDBE-D2A9-45C4-86F1-4B9ADECAF25DQ41889833-D6AA5E15-4A88-4293-A149-04A27CDF622DQ44927149-A3BB5381-D300-4B3C-9895-8A5DCB03A89FQ45074104-D2D398FF-7ECD-495E-BA94-67877F76B2E1Q47756168-AB3AC8A4-E573-4FB5-9198-E4F2DDD42747Q47853567-3CA1339F-ED59-40CD-BB0C-33A303B5D7A0Q48150621-89B30F49-2C5F-45AE-B9DD-008F3465093CQ48625336-EB76FCB5-B0F3-42AC-A932-8CACA7FFABD2Q50048334-B481E5FF-77F1-4E4D-9C8B-BD771D5AF2CDQ50053483-98F98BB7-EBE9-4C85-9460-1297C5659BE1Q52590985-961F56AC-544F-4AB4-BD0E-A61467C0C6A9
P2860
MiR-339-5p inhibits breast cancer cell migration and invasion in vitro and may be a potential biomarker for breast cancer prognosis
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
MiR-339-5p inhibits breast can ...... er for breast cancer prognosis
@ast
MiR-339-5p inhibits breast can ...... er for breast cancer prognosis
@en
type
label
MiR-339-5p inhibits breast can ...... er for breast cancer prognosis
@ast
MiR-339-5p inhibits breast can ...... er for breast cancer prognosis
@en
prefLabel
MiR-339-5p inhibits breast can ...... er for breast cancer prognosis
@ast
MiR-339-5p inhibits breast can ...... er for breast cancer prognosis
@en
P2093
P2860
P356
P1433
P1476
MiR-339-5p inhibits breast can ...... er for breast cancer prognosis
@en
P2093
Chao-Qun Wang
Gui-Hong Zhang
Jing-Jing Zhao
Nong Zhang
Shan-Shan Mao
Xiao-Chun Xu
Xiao-Nan Wang
Zheng-Sheng Wu
P2860
P2888
P356
10.1186/1471-2407-10-542
P407
P577
2010-10-09T00:00:00Z
P5875
P6179
1003870826